Meeting
2015 Genitourinary Cancers Symposium
Association of germline variation with androgen ablation (AA) failure in advanced hormone-sensitive prostate cancer (HSPC).
Authors
Samith Thomas Kochuparambil
Mayo Clinic, Rochester, MN, Rochester, MN
Samith Thomas Kochuparambil , Ben Yiming Zhang , Shaun M. Riska , Douglas W. Mahoney , Shannon McDonnell , Adam M Lee , Fernando Quevedo , Brian Addis Costello , Henry Clement Pitot , Ricardo Ribeiro , Rui Medeiros , Catia Monteiro , Augusto Nogueira , Joaquina Mauricio , Avelino Manuel Fraga , Fernando Eduardo Calais Da Silva , James Robert Cerhan , Manish Kohli
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 209)
DOI
10.1200/jco.2015.33.7_suppl.209
Abstract #
209
Poster Bd #
B2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Correlation of age and the tumor transcriptomic profile in patients (pts) with advanced prostate cancer (PCa).
First Author: Kamal Kant Kant Sahu
Poster
2018 ASCO Annual Meeting
Germline variant alleles in rs12422149 of SLCO2B1 and response to abiraterone acetate (AA) in men with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Andrew W Hahn
Poster
2015 Genitourinary Cancers Symposium
Germ line predictors of response to androgen deprivation therapy in men with advanced prostate cancer.
First Author: Neeraj Agarwal
Poster
2013 Genitourinary Cancers Symposium
Effect of dutasteride on tumor proliferation during the regrowth phase of intermittent androgen ablation therapy in men with advanced prostate cancer.
First Author: Daniel H. Shevrin